US2019184144A1PendingUtilityA1

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Assignee: RANI THERAPEUTICS LLCPriority: Dec 23, 2010Filed: Jun 18, 2018Published: Jun 20, 2019
Est. expiryDec 23, 2030(~4.4 yrs left)· nominal 20-yr term from priority
Inventors:Mir Imran
A61K 38/26A61K 38/28A61M 25/10A61K 9/4808A61M 31/002A61K 9/0053A61K 31/155A61K 45/06A61P 3/10A61M 2037/0023A61M 25/10185A61M 37/0015A61M 5/00
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Many embodiments provide a swallowable device for delivering the agents. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade to release the drug into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A therapeutic preparation comprising exenatide, the preparation adapted for insertion into an intestinal wall after oral ingestion, wherein upon insertion, the preparation releases exenatide into the blood stream from the intestinal wall to achieve a C max  in a shorter time period than a time period to achieve a C max  for an extravascularly injected dose of exenatide.

Join the waitlist — get patent alerts

Track US2019184144A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.